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DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING
June 15-16, 2020

Executive Summary
NM Highlights: NM case updates. Tribal outreach campaign. Santa Fe firefighters support first responders.
US Highlights: COVID-19 hospitalizations rise in Texas. US retail sales up in May. Projected COVID-19 deaths in
US.
International Highlights: COVID-19 prevention and control in Africa. COVID-19 response and challenge in
Africa.
Epidemiology Highlights: Herd immunity in Europe. Social distance measures effects. Modeling infections in
India. Fecal analysis. Wastewater-based Epidemiology Consortium.
Healthcare Policy Recommendations: Public health approach to lockdown debate. All of Us Program adds
new COVID-19 initiatives.
Practice Guidelines: Guidelines are reviewed on urology care. IBD endoscopy. Convalescent plasma use.
Testing: Patient predictors of risk for positive COVID-19 test are reported and an online risk calculator is now
available.
Drugs, Vaccines, Therapies, Clinical Trials: Steroid dexamethasone reduces 28-day mortality by 1/3. Research
links ‘inflamm-aging’ and cytokine storm in elderly. Cancer drug may reduce severe COVID-19. 48 new trials
registered.
Other Science: Postpone surgery. Proteins predict outcomes. Neurologic manifestations. Thromboembolic
risk. Zoonotic transmission. Liver failure. Cardiac complications.

All of our past briefings are maintained in a UNM library repository here.
Our continuously curated practice guidelines in the context of COVID-19 can be found here.
Our continuously curated therapeutic evidence is maintained here.
You may submit content for future briefings here.

NM Highlights


NM reports 7 more COVID-19 deaths and 88 additional cases on June 16
As of today (6/16), the total positive cases and total deaths in the state are 9,933 and 447, respectively. The state has
performed 271,553 tests, there are 156 individuals currently hospitalized for COVID-19, and 4,217 COVID-19 cases have
recovered. NMDOH portal featuring epidemiologic breakdown of cases.



New Mexico begins tribal outreach campaign amid coronavirus pandemic
Santa Fe New Mexican: New Mexico health officials have teamed with Native American cartoonist Ricardo Caté to increase

awareness about the coronavirus pandemic as part of a new campaign. His cartoon, Without Reservation, is published daily
in the Santa Fe New Mexican. Officials say the goal is to use culturally relevant messaging on how tribal members can take
precautions to protect their communities, families and elders.



Santa Fe County firefighters union creates nonprofit to support first responders
Santa Fe New Mexican: The Santa Fe County International Association of Firefighters Local 4366 launched the Santa Fe
County Firefighters Foundation last week to help raise money for community projects such as firewood drives as well as
firefighters and paramedics injured on the job. For more information visit here.

US Highlights


Texas reports record-breaking coronavirus hospitalizations
CNBC News: Texas health authorities said there were 2,287 patients sickened with Covid-19 across its hospitals on Sunday,
the sixth new high for coronavirus hospitalizations in the state in less than a week. In the past week, Wednesday was the only
day that Texas didn’t set a new record for hospitalizations. Texas was among the first states to relax its statewide stay-athome order, allowing it to expire April 30. Infectious disease experts say the steady rise in Covid-19 cases and hospitalizations
in Texas and other states will likely add to scrutiny from some U.S. lawmakers that some states opened businesses too early.



US retail sales bounce up 17.7% as states reopen
NPR: As more states and cities allowed restaurants and shopping centers to reopen, U.S. retail sales — a measure that
includes spending on gasoline, cars, food and drink — swung big in May, the U.S. Commerce Department said Tuesday.
Spending is still down 6.1% from a year earlier because of the coronavirus pandemic.



Model projects 200,000 COVID-19 deaths in the US by October
CNN: One model cited by the White House now predicts 200,000 deaths from coronavirus by October 1 -- an increase of
30,000 deaths since last week's projection by the Institute for Health Metrics and Evaluation at the University of Washington.
Increased mobility and premature relaxation of social distancing led to more infections in Florida, Arizona, and other states.

International Highlights


What works and doesn’t in response to COVID-19 prevention and control in Africa
International Journal of Infectious Diseases: The five countries with the highest cumulative number of cases in Africa are
South Africa, Egypt, Nigeria, Algeria, and Ghana. The lower number of COVID-19 cases in most African countries may be
attributed to inadequate health systems, low-to-absent testing capacity, poor reporting system and insufficient number of
medical staff. The COVID-19 pandemic poses a great threat to most African countries from cities to rural areas and has
created a strong demand on already scarce resources and requires an intense mobilization of additional resources to
implement established emergency contingency measures. Closure of borders and movements of people restrictions within
the country as measures to prevent the spread of COVID-19; this has resulted in the sector being adversely affected by the
loss of income. Cooperative prevention and control measures are one of the promising solutions to deplete the spread of
COVID-19 on the continent.



COVID-19 in Africa: status of the pandemic, response and challenges
Nature Medicine. As of 22 May 2020, 54 of 55 African Union (AU) Member States (except Western Sahara) had reported over
100,000 cases and 3,100 deaths. To respond to COVID-19, many AU Member States have been using a combination of
containment and mitigation measures. As early as 20 March 2020, AU Member States that had reported fewer than 100
cases were imposing lockdowns and curfews to prevent further COVID-19 transmission within their borders. Probably due to
these early efforts, some AU Member States have seen a reduction in average daily case growth. Implementation of the
Africa Joint Continental Strategy on COVID-19 will require US$420 million over the next six months to stop the COVID-19
pandemic. Although several AU Member States and private-sector donors have pledged contributions to the AU COVID-19
response fund, Africa will not be able to meet this demand on its own. International action and solidarity will be needed to
beat COVID-19.

Epidemiology Highlights


Herd immunity and deaths from COVID-19 in Europe
The Lancet: Transmission of SARS-CoV-2 is currently in marked decline in many countries in Europe, North America, and parts
of Asia. The observed declines in cases and deaths could be due to the achievement of herd immunity. However, there is
little evidence to support that herd immunity is responsible for the decline because there are large differences in patterns of
per-capita deaths in different countries that are difficult to reconcile with herd immunity arguments but are easily explained
by the timing and stringency of interventions. The herd immunity argument is also at odds with both mortality and
seroprevalence data,



The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series
analysis
GeroScience: The COVID-19 pandemic recently started declining in Europe following the introduction of unprecedented
"stay-at-home" national policies. Our research aims were to characterize the changepoint in the flow of the COVID-19
epidemic in each European country and to evaluate the association of the level of social distancing with the observed decline
in the national epidemics. Our findings identified the most probable changepoints in 28 European countries. Before
changepoint, incidence of new COVID-19 cases grew by 24% per day on average. From the changepoint, this growth rate was
reduced to 0.9%. The beneficial effect of higher social distance quartiles (i.e., turning the increase into decline) was
statistically significant for the fourth quartile. Notably, many countries in lower quartiles also achieved a flat epidemic curve.
In these countries, other plausible COVID-19 containment measures could contribute to controlling the first wave of the
disease. The association of social distance quartiles with viral spread could also be hindered by local bottlenecks in infection
control. These results allow for moderate optimism related to the gradual lifting of social distance measures in the general
population and call for specific attention to the protection of focal micro-societies enriching high-risk elderly subjects,
including nursing homes and chronic care facilities.



SARS-CoV-2 epidemiological features and SIR modeling of the effect of interventions in India
F1000 Research: A number of steps to limit the spread of the virus in the country have been taken in India including
restricted testing, isolation, contact tracing and quarantine, and enforcement of a nation-wide lockdown starting 25 March
2020. A cross-sectional descriptive analysis of the laboratory confirmed COVID-19 patient-wise data collected from a
crowdsourced database was completed. The median age of patients was 38 years with 20-39 year-old males being the most
affected group. The percent of affected patients who were men was 73.6% (854) and 26.4% (307) were women. A SIR
mathematical model estimated between 110,460 – 220,575 infected cases in India at the end of 40 days lockdown if the
current contact rate continues.. Interventions have been helpful in preventing the worst-case scenario in India, but will be
unable to prevent the spike in number of cases.



Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19
Journal of Infection: Recent studies show that SARS-CoV-2 RNA may be found in fecal specimens of COVID-19 patients, but
the sample size is limited. This systematic review and meta-analysis examined the detection rate of SARS-CoV-2 RNA in fecal
specimens of patients according to their clinical characteristics. The pooled detection rate of the RNA was 43.7% by patient
and 33.7% by specimens. Females compared to males (59.6% vs. 53.5%), those who presented with gastrointestinal
symptoms compared to those without gastrointestinal symptoms (77.1% vs. 57.7%), and patients with severe or critical
disease compared to those with mild or moderate disease (68.3% vs. 34.6%) tended to have a higher detection rate. A
significant proportion of COVID-19 patients (43.7%) carry SARS-CoV-2 in their intestinal tract. Feces being a self-collected
specimen bears a potential to improve case identification in community, especially for young children where proper
respiratory sampling at home is difficult. Specific infection control strategies focusing on spread via fecal contamination and
faulty toilet drainage are urgently needed.



Global collaborative announced for COVID-19 wastewater-based epidemiology
Environmental Science & Technology: In partnership with the Sewage Analysis CORe group Europe (SCORE) network and the
Global Water Pathogen Project, the COVID-19 WBE Collaborative was launched as a hub to coordinate and promote the
efforts of research groups undertaking WBE for COVID-19. The website will include content such as press releases,

commentaries, and media content for public outreach and will be used to solicit participation in the collaborative and
advertise events relevant to WBE. A workspace is also hosted for rapid informal communication regarding COVID-19 WBE,
and plan to host data and protocols for methodological coordination.

Healthcare Policy Recommendations


A public health approach to the 'lockdown' debate
BMJ Global Health: The current approach to assessing risks and defining interventions in the COVID-19 pandemic takes a
narrow medical/epidemiological view. A false dichotomy between saving lives and saving livelihoods has dominated the
decision-making on responses to the pandemic. A framework is proposed that includes the major elements of COVID-19related factors, health systems preparedness, non-COVID-19 medical conditions, social determinants and social protection,
with an illustration of its practical application. This, framework provides communities with more agency than one-size-fits-all
approaches to COVID-19 control while taking into account human rights, health systems and the SDH.



NIH’s All of Us Program joins fight against COVID-19
National Institutes of Health (NIH) press release: Dr. Francis Collins, Director of NIH, encourages everyone to join All of Us
Research Program to assist the scientific community in seeking new insights into COVID-19. The program announced three
initiatives including testing blood samples from the initiative's participants, standardization of the rapidly relevant COVID-19
diagnosed information, and deployment of a new online survey to better understand the effects of the pandemic on
participants' physical and mental health.

Practice Guidelines


A systematic review of guidelines and recommendations for urology standards of care
European Urology Focus: Of the 15 studied guidelines 14 addressed emergency situations and 12 reported on assessment of
elective uro-oncology procedures. There was consensus on postponing radical prostatectomy except for high-risk prostate
cancer, and delaying treatment for low-grade bladder cancer, small renal masses up to T2, and stage I seminoma. According
to 9 guidelines that addressed endourology, obstructed or infected kidneys should be decompressed, whereas nonobstructing stones and stent removal should be rescheduled. 5 guidelines discussed laparoscopic and robotic surgery, while
the remaining recommendations focused on the outpatient procedures and consultations. All recommendations represented
expert opinions, with three specifically endorsed by professional societies. Only the European Association of Urology
guidelines provided evidence-based levels of evidence (mostly level 3 evidence).



French recommendations for IBD endoscopy during COVID-19 pandemic
Nature reviews gastroenterology and hepatology: Société Française d'Endoscopie Digestive provides its recommendations.
Measures of prevention should be planned and adopted in all endoscopy units that manage patients with and without
inflammatory bowel diseases (IBD). In the management of IBD- specific endoscopic situations, alternative biomarkers
replacing non-urgent endoscopy, such as fecal calprotectin home test to assess disease activity, should be considered and
implemented. To understand whether endoscopy could be rescheduled, it is important to maintain close contact with
patients by phone or e-mail to monitor for specific symptoms (through the use of standardized questionnaires) and general
clinical condition as well as for indications of SARS- CoV-2 infection.



The guidelines on convalescent plasma use: differences between high and low-middle income countries
VoxSanguinis: A multidisciplinary, geographically representative group of individuals with expertise spanning transfusion
medicine, infectious diseases and hematology has developed the guidance for COVID-19 convalescent plasma (CCP) use.
Three subgroups (i.e. donor, product and patient) were established based on self-identified expertise and interest. A series of
questions pertaining to each domain was devised and addressed by the subgroups, based on the best available evidence.
Here, the donor and product-related challenges are summarized and contrasted between high-income countries (HICs) and
low-middle income countries (LMICs). Early challenges in HICs were related to recruitment and qualification of sufficient
donors to meet the growing demand. Antibody testing also posed a specific obstacle given the lack of standardization,
variable performance of the assays in use and uncertain interpretation of results. In LMICs, an extant transfusion deficit,

suboptimal models of donor recruitment (e.g. reliance on replacement and paid donors), limited laboratory capacity for predonation qualification and operational considerations could impede wide adoption. There has been wide scale adoption of
CCP in many HICs, which could increase if the clinical trials show its efficacy. By contrast, LMICs, having received little
attention, require locally applicable strategies for adoption of CCP.

Testing


Patient predictors of risk for positive COVID-19 test: an online risk calculator available
Chest: A prospective registry of 11,672 patients tested for COVID-19 in the Cleveland Clinic was used to investigate whether
statistical modeling based on patient characteristics can be used to accurately predict infection with COVID-19. Males,
African Americans, older patients, and those with known COVID-19 exposure were at higher risk of being COVID-19 (+). Risk
was reduced in those who had pneumococcal polysaccharide or influenza vaccine, or were on melatonin, paroxetine, or
carvedilol. The model had favorable discrimination (c-statistic=0.863 in development; 0.840 in validation cohort) and
calibration. The authors present sensitivity, specificity, negative predictive value, and positive predictive value at different
prediction cut-offs. A calculator for pretest probability of COVID-19 infection is publicly available.

Drugs, Vaccines, Therapies, Clinical Trials


UK RECOVERY trial finds steroid dexamethasone reduces mortality by 1/3 in severe COVID-19 cases
The UK National Institute of Health Research reports in a press release that their RECOVERY trial of dexamethasone shows
improved survival rates for ventilated patients with COVID-19 over usual care. A total of 2104 patients were randomized to
dexamethasone once per day for ten days and were compared with 4321 patients randomized to usual care alone. Among
the usual care control group, 28-day mortality was highest in those on ventilators (41%), intermediate in those on oxygen
only (25%), and lowest among those who were not receiving any respiratory intervention (13%). Overall, dexamethasone
reduced the risk of 28-day mortality by 17% with a highly significant trend showing greatest benefit among those on
ventilators. Mortality was reduced by 1/3 in ventilated patients and by 1/5 in patients receiving oxygen only. No evidence of
benefit was found for patients who did not receive oxygen and the study did not include patients outside the hospital setting.
Follow-up is complete for over 90% of participants. The trial results are not yet published in a peer-reviewed manuscript.



The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection
Inflammation Research: Novel Coronavirus disease 2019 (COVID-19), is an acute respiratory distress syndrome (ARDS). It has
proven that COVID-19 infection in some elderly critical adults leads to a cytokine storm, characterized by severe systemic
elevation of several pro-inflammatory cytokines. A cytokine storm can induce edematous, ARDS, pneumonia, as well as
multiple organ failure in aged patients. It is far from clear till now why cytokine storm induces in only COVID-19 elderly
patients, and not in young patients. However, it seems that aging is associated with mild elevated levels of local and systemic
pro-inflammatory cytokines, which is characterized by "inflamm-aging". It is highly likely that "inflamm-aging" is correlated to
increased risk of a cytokine storm in some critical elderly patients with COVID-19 infection. This review was to summarize
experimental data and clinical observations that linked the pathophysiology mechanisms of "inflamm-aging", mild-grade
inflammation, and cytokine storm in some elderly adults with severe COVID-19 infection.



Cancer drug (acalabrutinib) may reduce symptoms of severe COVID-19
NIH Research Matters: Hyperinflammatory state in patients with severe COVID-19 is known as a cytokine storm. Cytokines act
as chemical messengers that help to stimulate and direct the immune response. But when large amounts of cytokines are
released in the body, it can be dangerous. Currently, there are no proven treatment strategies for this phase of the illness. A
research team led by Drs. Wyndham H. Wilson, Louis M. Staudt, and Mark Roschewski at NIH’s National Cancer Institute (NCI)
and Mihalis Lionakis at NIH’s National Institute of Allergy and Infection Diseases (NIAID) tested the off-label use of a BTK
inhibitor called acalabrutinib to treat COVID-19. They carried out a clinical study of 19 patients with a confirmed COVID-19
diagnosis who required hospitalization and had low blood-oxygen levels and evidence of inflammation. Of these, 11 had been
receiving supplemental oxygen for a median of two days, and eight others had been on ventilators for a median of 1.5 days.



48 New COVID-19 Trials registered June 15-16 at clinicaltrials.gov
NIH U.S. National Library of Medicine: Treatment trials of Favipiravir, Pamrevlumab, Pulmozyme, Remdesivir, BAT2020,
Lianhua Qingwen, Ivermectin, Ivermectin + Doxycycline, Hydroxychloroquine + Azithromycin, PB1046, Doxycycline,
Dipyridamole, Pentoxifylline. At time of writing, a total of 2019 trials were active, 151 completed, and 4 posted results.

Other Science


High surgical mortality and complications in COVID-19 patients – postpone if possible
JAMA Surgery: In an Italian study, patients with COVID-19 were matched with patients without COVID-19. Of the 123 patients
of the combined cohorts (78 women [63.4%]; mean [SD] age, 76.6 [14.4] years), 30-day mortality was significantly higher for
those with COVID-19 compared with control patients without COVID-19 (odds ratio [OR], 9.5; 95% CI, 1.77-96.53).
Complications were also significantly higher (OR, 4.98; 95% CI, 1.81-16.07); pulmonary complications were the most common
(OR, 35.62; 95% CI, 9.34-205.55), but thrombotic complications were also significantly associated with COVID-19 (OR, 13.2;
95% CI, 1.48-infinity). Different models (cumulative link model and classification tree) identified COVID-19 as the main
variable associated with complications. The authors conclude that whenever possible, surgery should be postponed in
patients with COVID-19.



Leukocytosis and elevated C-reactive protein can predict worse outcomes: a meta-analysis
Clinica Chimica Acta: Eighteen studies with 3,278 patients were selected. Fever, leukocytosis, and elevated CRP were
associated with poor outcomes OR (95% CI) were 1.63 (1.06 to 2.51), 4.51 (2.53 to 8.04), and 11.97 (4.97 to 28.8),
respectively. Leukopenia was associated with a better prognosis (OR 0.56, 95% CI 0.40 to 0.78). Sensitivity analyses showed
similar tendencies. Meta-regression analysis for leukocytosis indicated that age, dyspnea, and hypertension contributed to
heterogeneity.



Neurological manifestations of COVID-19
Journal of Neurology: A meta-analysis of 41 studies for prevalence of nine neurologic COVID-19 manifestations in 3837
patients revealed that the most common manifestations were fatigue (33.2% [23.1-43.3]), anorexia (30.0% [23.2-36.9]),
dyspnea/shortness of breath (26.9% [19.2-34.6]), and malaise (26.7% [13.3-40.1]). The common specific neurological
symptoms included olfactory (35.7-85.6%) and gustatory (33.3-88.8%) disorders, especially in mild cases. Guillain-Barre
syndrome and acute inflammation of the brain, spinal cord, and meninges were repeatedly reported after COVID-19.
Laboratory, electrophysiological, radiological, and pathological evidence supported neurologic involvement of COVID-19.



Thromboembolic risks in patients with COVID-19
Pan African Medical Journal: COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality
worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular
inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under
clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of
this disorder should be essential in order to reduce mortality in these patients.



Animals can be reservoir for MERS-CoV and SARS-CoV infections: a meta-analysis
Infez Med: From a total of 34 studies (n=20,896 animals), the pool prevalence by RT-PCR for MERS-CoV was 7.2% (95%CI 5.68.7%), with 97.3% occurring in camels, in which pool prevalence was 10.3% (95%CI 8.3-12.3). Qatar was the country with the
highest MERS-CoV RT-PCR pool prevalence: 32.6% (95%CI 4.8-60.4%). From 5 studies and 2,618 animals, for SARS-CoV, the
RT-PCR pool prevalence was 2.3% (95%CI 1.3-3.3). Of those, 38.35% were reported on bats, in which the pool prevalence was
14.1% (95%CI0.0-44.6%). Thus, a considerable proportion of infected animals tested positive, particularly by nucleic acid
amplification tests (NAAT). Camels and bats were found to be positive by RT-PCR in over 10% of the cases for both; thus,
suggesting their relevance in the maintenance of wild zoonotic transmission.



Risk of hepatic failure in COVID-19 patients
Infez Med: A total of 4191 COVID-19 patients were included in the meta-analysis. The pooled prevalence of liver injury was
19.5% (95% CI: 14.3-26.1). There was significant heterogeneity among the 19 studies (X2 = 738.5; p < 0.001; I2 = 94.34%).
Among 288 death cases, the pooled prevalence of liver injury was 22.8% (95% CI: 11.7-39.8). In summary, the COVID-19

disease itself can result in severe and even fatal respiratory diseases and even may lead to ARDS and multiple organ failure.
The results of this systematic review highlight the importance of liver injury that may assist clinicians anywhere in the globe
in controlling COVID-19-related infection and complications. Moreover, the prevalence of liver injury can be higher in severe
cases than in mild cases.



A review of cardiac complications in COVID-19
Cureus: SARS-CoV-2 infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis.
Virus-related myocardial injury is associated with inflammation, impairment of cardiac function, and malignant ventricular
tachyarrhythmias. When COVID-19 is complicated by acute myocardial injury, a significant increase in mortality occurs. The
authors urge physician awareness of the elevated morbidity and mortality of myocardial involvement in COVID-19. They
anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19
patients with severe symptoms.

Contributing team members: Christophe G. Lambert, Shawn Stoicu, Lori Sloane, Mari Anixter, Anastasiya
Nestsiarovich, Praveen Kumar, Nicolas Lauve, Morgan Edwards-Fligner, Clinton Onyango, Cristian Bologa,
Kristine Tollestrup, Douglas J. Perkins.

Disclaimer: The UNM Global Health COVID-19 Briefing is provided as a public service. Sources include not only
peer-reviewed literature, but also preliminary research manuscripts that have not been peer reviewed along
with lay news media reports. The peer-review process often results in manuscript improvement, with
corrections made for errors and unsubstantiated conclusions being corrected. Furthermore, many headlines
and summaries in the briefing are written by student volunteers and others who may lack subject matter
expertise in this rapidly evolving field. As such, the headlines and summaries should not be regarded as
conclusive. Instead, readers are encouraged to use the briefing to identify areas of interest and then use the
embedded links to read and critically evaluate the primary sources.

